Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies

Jacob A Miller, Rupesh Kotecha; Manmeet Ahluwalia; Alireza M Mohammadi, Samuel T Chao, Gene H Barnett, Erin S Murphy, Michael A Vogelbaum, Lilyana Angelov, David M Peereboom, John H Suh

Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies

Jacob A Miller, Rupesh Kotecha
, Manmeet Ahluwalia
, Alireza M Mohammadi, Samuel T Chao, Gene H Barnett, Erin S Murphy, Michael A Vogelbaum, Lilyana Angelov, David M Peereboom, John H Suh

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer
Volume	123
State	Published - Jun 15 2017

Disciplines

Medicine and Health Sciences

Cite this

Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies. / Rupesh Kotecha, Jacob A Miller,; Ahluwalia, Manmeet; John H Suh, Alireza M Mohammadi, Samuel T Chao, Gene H Barnett, Erin S Murphy, Michael A Vogelbaum, Lilyana Angelov, David M Peereboom,.
In: Cancer, Vol. 123, 15.06.2017.

Research output: Contribution to journal › Article › peer-review

@article{3359b01734b44b88b96007c6a2ba9b28,

title = "Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies",

author = "\{Rupesh Kotecha\}, \{Jacob A Miller,\} and Manmeet Ahluwalia and \{John H Suh\}, \{Alireza M Mohammadi, Samuel T Chao, Gene H Barnett, Erin S Murphy, Michael A Vogelbaum, Lilyana Angelov, David M Peereboom,\}",

note = "Molecular subtypes appear to be prognostic for survival and predictive of the response to radiotherapy. TKIs were found to improve survival and local control, and may decrease the rate of distant failure. To preserve neurocognition, these results support a paradigm of upfront radiosurgery and HER2-d ...",

year = "2017",

month = jun,

day = "15",

language = "American English",

volume = "123",

journal = "Cancer",

}

TY - JOUR

T1 - Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies

AU - Rupesh Kotecha, Jacob A Miller,

AU - Ahluwalia, Manmeet

AU - John H Suh, Alireza M Mohammadi, Samuel T Chao, Gene H Barnett, Erin S Murphy, Michael A Vogelbaum, Lilyana Angelov, David M Peereboom,

N1 - Molecular subtypes appear to be prognostic for survival and predictive of the response to radiotherapy. TKIs were found to improve survival and local control, and may decrease the rate of distant failure. To preserve neurocognition, these results support a paradigm of upfront radiosurgery and HER2-d ...

PY - 2017/6/15

Y1 - 2017/6/15

UR - https://pubmed.ncbi.nlm.nih.gov/28192598/

M3 - Article

VL - 123

JO - Cancer

JF - Cancer

ER -

Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies

Disciplines

Other files and links

Cite this